Keyphrases
Head-and-neck Cancer
95%
Sensing Receptors
92%
GPR39
92%
Zinc Detection
92%
Colonocytes
73%
Patient-derived Xenograft
54%
Tumor
47%
Phosphoinositide 3-kinase (PI3K)
40%
Insulin-like Growth Factor 1 Receptor (IGF1R)
36%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
30%
Tumor Cells
30%
Zn2+
30%
HT-29
29%
Isoform-selective Inhibitor
27%
Tumor Microenvironment
26%
PIK3CA
26%
N719
26%
Colon
26%
Targeted Therapy
26%
Tumor Cell Proliferation
25%
Experimental Colitis
23%
Calcium Signaling
23%
Metabotropic
23%
Immunotherapy Efficacy
23%
Tissue Explant Culture
23%
Prioritization Tool
23%
Cetuximab
23%
Phosphatidylinositol 4-phosphate 5-kinase (PIP5K)
23%
Insulin-like Growth Factor 2 (IGF2)
23%
HER3
23%
Human Epidermal Growth Factor Receptor 2 (HER2)
23%
Activator protein-1 (AP-1)
23%
Overcoming Resistance
23%
Blockage
23%
PI3Kα
23%
Zinc Signal
23%
Pituitary
23%
Butyrate
23%
Clusterin
23%
Cancer-associated Fibroblasts
23%
Induced Cell Death
23%
Tumor Tissue
23%
Extracellular pH
23%
Recombinant
23%
Receptor Downregulation
23%
Carboxyl Terminus
23%
Transforming Growth Factor-β
23%
Receptor Signaling
23%
Ovarian Cancer
23%
Heparan Sulfate Proteoglycans
23%
Medicine and Dentistry
Receptor
55%
Head and Neck Cancer
46%
Somatomedin
46%
Tumor Cell
41%
Neoplasm
38%
Taselisib
30%
Alpelisib
30%
Immunotherapy
30%
In Vitro
25%
Xenograft
25%
Cancer Inhibition
25%
Cell Proliferation
24%
Tumor Microenvironment
24%
Zinc Ion
23%
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase
23%
Receptor Upregulation
23%
Fibrinogen
23%
Ovarian Cancer
23%
Prothrombin
23%
Tumor Immune Microenvironment
23%
Phosphoinositide 3-Kinase Inhibitor
23%
Upregulation
22%
Tumor Progression
21%
Head and Neck Squamous Cell Carcinoma
19%
Trametinib
16%
Cancer Therapy
15%
Insulin-Like Growth Factor 1
15%
Calcium Ion
15%
Sodium Ion
15%
Epithelial Cell
15%
Alanine
15%
Esophageal Squamous Cell Carcinoma
15%
Histidine
15%
RNA Sequencing
15%
Immune Response
15%
Phosphoinositide 3-Kinase
15%
Cytotoxic T-Cell
14%
Antineoplastic Activity
13%
Cell Line
11%
Antiproliferative Activity
11%
Colony Stimulating Factor 1
11%
Malignant Neoplasm
11%
Mammalian Target of Rapamycin
10%
Flow Cytometry
10%
Signal Transduction
7%
Immunohistochemistry
7%
Kinase Assay
7%
Mitogen Activated Protein Kinase 3
7%
Mass Spectrum
7%
Nuclear Magnetic Resonance Spectroscopy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Head and Neck Cancer
94%
Receptor
59%
Malignant Neoplasm
51%
Somatomedin
42%
Taselisib
29%
Alpelisib
29%
Immunotherapy
28%
Head and Neck Squamous Cell Carcinoma
26%
Small Interfering RNA
26%
Cancer Inhibition
24%
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase
23%
Transforming Growth Factor Beta
23%
Experimental Colitis
23%
Cetuximab
23%
Phosphatidylinositol 3 Kinase Inhibitor
23%
Dextran Sulfate
23%
Fibrinogen
23%
Ovary Cancer
23%
Nanoparticle
23%
Prothrombin
19%
Tumor Microenvironment
18%
Tumor Growth
17%
Esophageal Squamous Cell Carcinoma
15%
Phosphatidylinositol 3 Kinase
13%
Insulin-Like Growth Factor 1
13%
Mouse Model
11%
Trametinib
11%
Flow Cytometry
11%
CD8 Antigen
10%
Occludin
9%
Wild Type Mouse
9%
Disease
9%
Antitumor Activity
8%
Colony Stimulating Factor 1
8%
Mouse
8%
Human Papillomavirus
7%
anthra[1,9 Cd]pyrazol 6(2h) One
7%
Colitis
6%
Calcium Ion
6%
Knockout Mouse
6%
Clinical Trial
6%
Inflammation
6%
Combination Drug
6%
Therapeutic Window
5%
Cancer Growth
5%
Western Blot
5%
Enzyme-Linked Immunosorbent Assay
5%
NOD SCID Gamma Mouse
5%
Pharmacokinetics
5%
